These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21300978)

  • 1. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.
    Chen J; Hobbs WE; Le J; Lenting PJ; de Groot PG; López JA
    Blood; 2011 Mar; 117(13):3680-3. PubMed ID: 21300978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
    Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
    J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.
    Zhou Z; Yee DL; Guchhait P
    Curr Vasc Pharmacol; 2012 Nov; 10(6):756-61. PubMed ID: 22272904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 activity in sickle cell disease.
    Schnog JJ; Kremer Hovinga JA; Krieg S; Akin S; Lämmle B; Brandjes DP; Mac Gillavry MR; Muskiet FD; Duits AJ;
    Am J Hematol; 2006 Jul; 81(7):492-8. PubMed ID: 16755558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
    Al-Awadhi A; Adekile A; Marouf R
    Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.
    Hulstein JJ; de Groot PG; Silence K; Veyradier A; Fijnheer R; Lenting PJ
    Blood; 2005 Nov; 106(9):3035-42. PubMed ID: 16014562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
    Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of ADAMTS13-independent VWF regulation in sickle cell disease.
    Hunt RC; Katneni U; Yalamanoglu A; Indig FE; Ibla JC; Kimchi-Sarfaty C
    J Thromb Haemost; 2022 Sep; 20(9):2098-2108. PubMed ID: 35753044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Hulstein JJ; van Runnard Heimel PJ; Franx A; Lenting PJ; Bruinse HW; Silence K; de Groot PG; Fijnheer R
    J Thromb Haemost; 2006 Dec; 4(12):2569-75. PubMed ID: 16968329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
    Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
    Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS-13-VWF axis in sickle cell disease patients.
    Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA
    Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
    Fogarty H; Ahmad A; Atiq F; Doherty D; Ward S; Karampini E; Rehill A; Leon G; Byrne C; Geoghegan R; Conroy H; Byrne M; Budde U; Schneppenheim S; Sheehan C; Ngwenya N; Baker RI; Preston RJS; Tuohy E; McMahon C; O'Donnell JS
    Blood Adv; 2023 Nov; 7(22):6974-6989. PubMed ID: 37773926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.
    Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
    Larkin D; de Laat B; Jenkins PV; Bunn J; Craig AG; Terraube V; Preston RJ; Donkor C; Grau GE; van Mourik JA; O'Donnell JS
    PLoS Pathog; 2009 Mar; 5(3):e1000349. PubMed ID: 19300493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood.
    Tsai HM; Sarode R; Downes KA
    Thromb Res; 2002 Nov; 108(2-3):121-5. PubMed ID: 12590947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.